东方生物
(688298)
| 流通市值：50.28亿 | | | 总市值：50.28亿 |
| 流通股本：2.02亿 | | | 总股本：2.02亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 2,500,715,509.52 | 2,604,809,193.17 | 3,081,496,804.8 | 2,862,715,435.64 |
| 交易性金融资产 | 316,732,715.07 | 328,896,295.38 | 207,578,258.72 | 843,806,254.98 |
| 应收票据及应收账款 | 193,388,585.06 | 192,372,694.5 | 230,166,750.51 | 272,856,154.48 |
| 其中：应收票据 | 1,849,025 | 1,276,455 | 2,084,470.32 | 1,804,684.99 |
| 应收账款 | 191,539,560.06 | 191,096,239.5 | 228,082,280.19 | 271,051,469.49 |
| 预付款项 | 36,063,307.39 | 32,136,394.49 | 28,448,863.11 | 37,836,957.12 |
| 其他应收款合计 | 10,855,213.95 | 17,010,163.95 | 19,115,158.73 | 20,365,778.31 |
| 存货 | 313,048,970.1 | 296,948,644.63 | 308,960,712.66 | 427,260,228.2 |
| 其他流动资产 | 116,499,255.51 | 111,736,085.37 | 102,998,159.39 | 95,749,351.23 |
| 流动资产合计 | 3,487,303,556.6 | 3,583,909,471.49 | 3,978,764,707.92 | 4,560,590,159.96 |
| 非流动资产: | | | | |
| 长期股权投资 | 19,144,645.93 | 26,267,094.66 | 20,418,460.71 | 19,552,807.88 |
| 其他非流动金融资产 | 30,122,602.91 | 29,700,752.49 | 29,846,844.66 | 30,727,585.05 |
| 投资性房地产 | - | - | - | 19,725,521.65 |
| 固定资产 | 1,512,291,030.11 | 1,526,229,795.9 | 1,541,055,701.04 | 1,480,517,831.21 |
| 在建工程 | 1,242,036,323.01 | 1,228,302,023.42 | 1,134,471,278.02 | 964,133,871.35 |
| 使用权资产 | 40,617,805.32 | 60,390,877.27 | 65,092,573.59 | 71,998,913.32 |
| 无形资产 | 651,719,741.64 | 670,752,732.8 | 690,906,710.19 | 712,952,668.84 |
| 商誉 | - | - | - | 55,367,499.57 |
| 长期待摊费用 | 50,588,936.91 | 54,527,494.18 | 59,710,254.96 | 61,443,673.5 |
| 递延所得税资产 | 268,595,531.72 | 271,730,195.99 | 268,465,824.07 | 233,749,890.27 |
| 其他非流动资产 | 308,200,962.78 | 307,351,513.43 | 305,847,891.38 | 23,643,591.28 |
| 非流动资产合计 | 4,123,317,580.33 | 4,175,252,480.14 | 4,115,815,538.62 | 3,673,813,853.92 |
| 资产总计 | 7,610,621,136.93 | 7,759,161,951.63 | 8,094,580,246.54 | 8,234,404,013.88 |
| 流动负债: | | | | |
| 短期借款 | 167,962,333.89 | 177,519,344.8 | 116,779,303.25 | 186,735,657.38 |
| 应付票据及应付账款 | 452,982,699 | 480,754,141.22 | 515,489,098.34 | 380,038,865.78 |
| 其中：应付票据 | - | - | - | 3,000,000 |
| 应付账款 | 452,982,699 | 480,754,141.22 | 515,489,098.34 | 377,038,865.78 |
| 预收款项 | - | 0 | - | - |
| 合同负债 | 32,142,326.17 | 35,768,144.35 | 30,987,531.76 | 33,556,760.78 |
| 应付职工薪酬 | 35,913,612.4 | 35,660,662.81 | 61,148,228.76 | 40,731,287.01 |
| 应交税费 | 5,954,684.8 | 9,701,395.04 | 14,895,003.73 | 3,696,722.74 |
| 其他应付款合计 | 114,524,887.06 | 115,334,047.58 | 138,393,080.87 | 143,521,360.39 |
| 一年内到期的非流动负债 | 16,884,465.38 | 30,788,482.47 | 324,816,838.85 | 324,199,973.87 |
| 其他流动负债 | 1,200,613.34 | 1,199,274.34 | 1,292,487.98 | 1,488,852.84 |
| 流动负债合计 | 827,565,622.04 | 886,725,492.61 | 1,203,801,573.54 | 1,113,969,480.79 |
| 非流动负债: | | | | |
| 长期借款 | 114,133,950 | 115,133,950 | - | - |
| 租赁负债 | 30,179,874.41 | 40,498,031.73 | 47,166,578.69 | 53,160,520.66 |
| 长期应付款 | 7,968,133.12 | 7,678,821.73 | 7,492,019.94 | - |
| 预计负债 | 6,192,900 | 17,622,000 | 17,469,666 | 5,906,943 |
| 递延收益 | 26,544,312.6 | 26,771,826.36 | 26,984,585.04 | 10,110,237.54 |
| 递延所得税负债 | 109,535.33 | 0 | 232,666.69 | 29,510.29 |
| 非流动负债合计 | 185,128,705.46 | 207,704,629.82 | 99,345,516.36 | 69,207,211.49 |
| 负债合计 | 1,012,694,327.5 | 1,094,430,122.43 | 1,303,147,089.9 | 1,183,176,692.28 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 201,600,000 | 201,600,000 | 201,600,000 | 201,600,000 |
| 资本公积 | 397,885,635.81 | 397,885,635.81 | 397,885,635.81 | 396,393,270.49 |
| 减:库存股 | 276,947,754.62 | 276,947,754.62 | 276,947,754.62 | 276,947,754.62 |
| 其他综合收益 | 33,076,055.46 | 47,081,400.1 | 54,902,604.6 | 24,820,019.4 |
| 盈余公积 | 84,000,000 | 84,000,000 | 84,000,000 | 84,000,000 |
| 未分配利润 | 6,020,553,040.36 | 6,068,198,335.36 | 6,183,650,819.31 | 6,450,517,323.76 |
| 归属于母公司股东权益合计 | 6,460,166,977.01 | 6,521,817,616.65 | 6,645,091,305.1 | 6,880,382,859.03 |
| 少数股东权益 | 137,759,832.42 | 142,914,212.55 | 146,341,851.54 | 170,844,462.57 |
| 股东权益合计 | 6,597,926,809.43 | 6,664,731,829.2 | 6,791,433,156.64 | 7,051,227,321.6 |
| 负债和股东权益合计 | 7,610,621,136.93 | 7,759,161,951.63 | 8,094,580,246.54 | 8,234,404,013.88 |
| 公告日期 | 2025-08-29 | 2025-04-30 | 2025-04-30 | 2024-10-31 |
| 审计意见(境内) | | | 标准无保留意见 | |